FMC Corporation (FMC)
| Market Cap | 815.06M -77.9% |
| Revenue (ttm) | 3.25B -21.3% |
| Net Income | -2.76B |
| EPS | -22.03 |
| Shares Out | 155.55M |
| PE Ratio | n/a |
| Forward PE | 3.83 |
| Dividend | $0.32 (6.07%) |
| Ex-Dividend Date | Sep 30, 2026 |
| Volume | 21,259,739 |
| Open | 5.12 |
| Previous Close | 8.09 |
| Day's Range | 4.85 - 5.64 |
| 52-Week Range | 4.85 - 31.30 |
| Beta | 0.46 |
| Analysts | Hold |
| Price Target | 12.51 (+138.74%) |
| Earnings Date | Oct 29, 2026 |
About FMC
FMC Corporation, an agricultural sciences company, develops, markets, and sells crop protection chemicals in Latin America, North America, Europe, the Middle East, Africa, and Asia. The company offers crop protection chemicals, including insecticides, herbicides, and fungicides. It also provides biologicals, crop nutrition, and seed treatment products. It markets its products through its sales organization and alliance partners, independent distributors, and sales representatives. The company was founded in 1883 and is headquartered in Philadel... [Read more]
Financial Performance
Financial StatementsAnalyst Summary
According to 17 analysts, the average rating for FMC stock is "Hold." The 12-month stock price target is $12.51, which is an increase of 138.74% from the latest price.
News
FMC price target lowered to $10 from $12 at Mizuho
Mizuho analyst Edlain Rodriguez lowered the firm’s price target on FMC (FMC) to $10 from $12 and keeps an Outperform rating on the shares. FMC is taking a $625M-$650M charge…
Corteva exposure to generic pressure ‘more modest’ than FMC, says Citi
After FMC (FMC) cut revenue and adjusted EBITDA forecasts and noted weaker than expected demand and elevated high-priced channel inventory limiting replenishment demand, Citi notes that the company’s ...
RBC Capital sees negative reaction to FMC’s Q3 preannouncement
RBC Capital tells investors in a research note that FMC (FMC) slashed Q3 EBITDA guidance to $538M from the previous midpoint of $130M, largely due to $650M in commercial actions,…
FMC price target lowered to $4 from $9 at Barclays
Barclays analyst Benjamin Theurer lowered the firm’s price target on FMC (FMC) to $4 from $9 and keeps an Underweight rating on the shares. The company cut its fiscal Q3…
FMC price target lowered to $9 from $11 at RBC Capital
RBC Capital lowered the firm’s price target on FMC (FMC) to $9 from $11 and keeps a Sector Perform rating on the shares as part of a broader research note…
FMC Stock Plummets 38% on Horrendous Guidance
Shares of crop chemical maker FMC plunged Thursday after the company provided deeply disappointing guidance.
FMC provides overview of commercial actions
The critical commercial issue facing FMC (FMC) is slower-than-expected demand from channel customers in key markets. Under current market conditions, distributors are seeking to operate with the lowes...
FMC down 28% to $5.85 after cutting Q3 guidance
07:37 EDT FMC (FMC) down 28% to $5.85 after cutting Q3 guidance
FMC Corporation Provides Update to Third-Quarter Expectations and Announces Comprehensive Commercial Actions to Expedite Return to Growth
Third-quarter revenue 1 is now expected to be $65 million to $125 million, with Adjusted EBITDA 2 expected to be negative $565 million to negative $510 million Revised expectations now include commerc...
FMC price target lowered to $12 from $15 at Mizuho
Mizuho analyst Edlain Rodriguez lowered the firm’s price target on FMC (FMC) to $12 from $15 and keeps an Outperform rating on the shares. The firm adjusted targets in the…
FMC price target lowered to $11 from $14 at BMO Capital
BMO Capital lowered the firm’s price target on FMC (FMC) to $11 from $14 and keeps a Market Perform rating on the shares as part of a broader research note…
FMC price target lowered to $10 from $12 at UBS
UBS lowered the firm’s price target on FMC (FMC) to $10 from $12 and keeps a Neutral rating on the shares.
FMC submits regulatory dossier for rimisoxafen to Brazilian authorities
FMC (FMC) announced the submission of the regulatory dossier for rimisoxafen to Brazilian regulatory authorities. The filing marks the second global regulatory submission for rimisoxafen, the first an...
FMC Corporation Submits Regulatory Dossier for Rimisoxafen, the Industry's First Dual Mode of Action Herbicide, in Brazil
Second global filing advances rimisoxafen as a novel weed control solution for Brazil's more than 70 million hectares of corn and soybeans PHILADELPHIA, Sept. 28, 2026 /PRNewswire/ -- FMC Corporation ...
FMC receives minority investment from Belgian-based Tessenderlo Group
FMC (FMC) and Tessenderlo Group, a Belgian-based industrial group, announced the closing of a minority equity investment by Tessenderlo Group in FMC. The companies entered into a definitive agreement ...
FMC Corporation and Tessenderlo Group Complete Minority Equity Investment
PHILADELPHIA, Sept. 23, 2026 /PRNewswire/ -- FMC Corporation (NYSE: FMC), a leading global agricultural sciences company, and Tessenderlo Group (XBRU: TESB), a Belgian-based industrial group, today an...
FMC Corporation announces date for third quarter 2026 earnings release and webcast conference call
PHILADELPHIA, Sept. 21, 2026 /PRNewswire/ -- FMC Corporation (NYSE: FMC) announced today it will release its third quarter 2026 earnings on Thursday, October 29, 2026, after the stock market close via...
FMC, AgroSpheres advance bioinsecticide pipeline into field trials
AgroSpheres and FMC (FMC) Corporation announced ab advancement in its ongoing collaboration. Two proprietary RNA-based biomolecule candidates from AgroSpheres’ pipeline are now entering global field t...
FMC initiated with an Overweight at KeyBanc
KeyBanc analyst Salvator Tiano initiated coverage of FMC (FMC) with an Overweight rating and $16 price target The firm rolled out coverage on 19 chemical and agriculture companies, with nine…
FMC Corporation Transcript: Jefferies Global Industrials Conference 2026
Stable demand and cautious inventory management persist in crop protection chemicals, with strategic investments and manufacturing changes set to drive growth from 2027. Key product launches and regulatory milestones are expected in 2027–2028, while R&D and digital tools remain central to future strategy.
FMC Corporation CEO Pierre Brondeau and CFO Andrew Sandifer to speak at the 2026 Jefferies Global Industrials Conference
PHILADELPHIA, Aug. 27, 2026 /PRNewswire/ -- FMC Corporation (NYSE: FMC) today announced that Pierre Brondeau, FMC chairman, chief executive officer and president, and Andrew Sandifer, FMC executive vi...
FMC resumed with a Neutral at BofA
BofA resumed coverage of FMC (FMC) with a Neutral rating and $12 price target Along with Q2 results, FMC lowered its full-year outlook, which resets the back half sharply lower,…
KBRA Assigns Ratings to FMC GMSR Issuer Trust, Series 2026-GT1 (FMC GMSR 2026-GT1)
NEW YORK--(BUSINESS WIRE)-- #creditratingagency--KBRA assigns ratings of ‘BBB- (sf)' to the Series 2026-GT1, Class A Term Notes from FMC GMSR ISSUER TRUST, Freedom Mortgage Corporation's (FMC) master ...
FMC price target lowered to $21 from $26 at Seaport Research
Seaport Research lowered the firm’s price target on FMC (FMC) to $21 from $26 and keeps a Buy rating on the shares, citing continued competitive challenges.
FMC Corporation Earnings Call Transcript: Q2 2026
Q2 EBITDA exceeded guidance despite sales headwinds from challenging market conditions, with strong free cash flow and significant progress on debt reduction. Full-year outlook was revised downward due to persistent pricing and volume pressures, but Q4 is expected to return to growth, driven by new products and improved cost structure.